nodes	percent_of_prediction	percent_of_DWPC	metapath
Adenosine—ADK—Abacavir—acquired immunodeficiency syndrome	0.422	1	CbGbCtD
Adenosine—Nelarabine—Abacavir—acquired immunodeficiency syndrome	0.15	0.351	CrCrCtD
Adenosine—Cladribine—Abacavir—acquired immunodeficiency syndrome	0.134	0.316	CrCrCtD
Adenosine—Cytarabine—Lamivudine—acquired immunodeficiency syndrome	0.0743	0.175	CrCrCtD
Adenosine—Decitabine—Lamivudine—acquired immunodeficiency syndrome	0.0672	0.158	CrCrCtD
Adenosine—ADORA1—nerve—acquired immunodeficiency syndrome	0.00243	0.0579	CbGeAlD
Adenosine—DPP4—Peptide hormone metabolism—ENPEP—acquired immunodeficiency syndrome	0.00197	0.107	CbGpPWpGaD
Adenosine—DPP4—blood plasma—acquired immunodeficiency syndrome	0.00185	0.0441	CbGeAlD
Adenosine—Cladribine—POLE3—acquired immunodeficiency syndrome	0.0018	0.556	CrCbGaD
Adenosine—SLC28A3—digestive system—acquired immunodeficiency syndrome	0.00138	0.0329	CbGeAlD
Adenosine—SLC28A3—bone marrow—acquired immunodeficiency syndrome	0.00127	0.0303	CbGeAlD
Adenosine—SLC28A3—lung—acquired immunodeficiency syndrome	0.00115	0.0275	CbGeAlD
Adenosine—ADK—retina—acquired immunodeficiency syndrome	0.00105	0.0249	CbGeAlD
Adenosine—Glucosamine—IFNG—acquired immunodeficiency syndrome	0.00101	0.313	CrCbGaD
Adenosine—ADORA2B—blood—acquired immunodeficiency syndrome	0.000936	0.0223	CbGeAlD
Adenosine—ADK—skin of body—acquired immunodeficiency syndrome	0.000918	0.0219	CbGeAlD
Adenosine—ADA—lymphoid tissue—acquired immunodeficiency syndrome	0.00091	0.0217	CbGeAlD
Adenosine—ADA—digestive system—acquired immunodeficiency syndrome	0.000899	0.0214	CbGeAlD
Adenosine—ADORA2B—vagina—acquired immunodeficiency syndrome	0.000868	0.0207	CbGeAlD
Adenosine—ADA—blood—acquired immunodeficiency syndrome	0.000857	0.0204	CbGeAlD
Adenosine—ADA—bone marrow—acquired immunodeficiency syndrome	0.000829	0.0198	CbGeAlD
Adenosine—ADORA2A—lymphoid tissue—acquired immunodeficiency syndrome	0.000828	0.0197	CbGeAlD
Adenosine—ADA—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000825	0.0446	CbGpPWpGaD
Adenosine—ADORA2B—lung—acquired immunodeficiency syndrome	0.000821	0.0196	CbGeAlD
Adenosine—ADA—vagina—acquired immunodeficiency syndrome	0.000794	0.0189	CbGeAlD
Adenosine—ADORA2A—blood—acquired immunodeficiency syndrome	0.000779	0.0186	CbGeAlD
Adenosine—ADORA2B—nervous system—acquired immunodeficiency syndrome	0.00076	0.0181	CbGeAlD
Adenosine—ADA—lung—acquired immunodeficiency syndrome	0.000751	0.0179	CbGeAlD
Adenosine—ADORA2A—spinal cord—acquired immunodeficiency syndrome	0.000751	0.0179	CbGeAlD
Adenosine—ADK—lymphoid tissue—acquired immunodeficiency syndrome	0.000744	0.0177	CbGeAlD
Adenosine—ADORA2B—central nervous system—acquired immunodeficiency syndrome	0.000732	0.0174	CbGeAlD
Adenosine—DPP4—lymphoid tissue—acquired immunodeficiency syndrome	0.000721	0.0172	CbGeAlD
Adenosine—DPP4—digestive system—acquired immunodeficiency syndrome	0.000712	0.017	CbGeAlD
Adenosine—ADK—blood—acquired immunodeficiency syndrome	0.0007	0.0167	CbGeAlD
Adenosine—ADA—nervous system—acquired immunodeficiency syndrome	0.000695	0.0166	CbGeAlD
Adenosine—DPP4—blood—acquired immunodeficiency syndrome	0.000679	0.0162	CbGeAlD
Adenosine—ADK—bone marrow—acquired immunodeficiency syndrome	0.000677	0.0161	CbGeAlD
Adenosine—ADK—spinal cord—acquired immunodeficiency syndrome	0.000674	0.0161	CbGeAlD
Adenosine—ADA—central nervous system—acquired immunodeficiency syndrome	0.000669	0.016	CbGeAlD
Adenosine—DPP4—bone marrow—acquired immunodeficiency syndrome	0.000657	0.0156	CbGeAlD
Adenosine—ADK—vagina—acquired immunodeficiency syndrome	0.000649	0.0155	CbGeAlD
Adenosine—ADORA1—spinal cord—acquired immunodeficiency syndrome	0.000648	0.0154	CbGeAlD
Adenosine—ADORA2A—nervous system—acquired immunodeficiency syndrome	0.000633	0.0151	CbGeAlD
Adenosine—DPP4—vagina—acquired immunodeficiency syndrome	0.000629	0.015	CbGeAlD
Adenosine—ADORA1—vagina—acquired immunodeficiency syndrome	0.000624	0.0149	CbGeAlD
Adenosine—ADK—lung—acquired immunodeficiency syndrome	0.000614	0.0146	CbGeAlD
Adenosine—ADORA1—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000613	0.0332	CbGpPWpGaD
Adenosine—ADORA2A—central nervous system—acquired immunodeficiency syndrome	0.000609	0.0145	CbGeAlD
Adenosine—DPP4—lung—acquired immunodeficiency syndrome	0.000595	0.0142	CbGeAlD
Adenosine—ADORA1—lung—acquired immunodeficiency syndrome	0.00059	0.0141	CbGeAlD
Adenosine—ADORA2B—brain—acquired immunodeficiency syndrome	0.000581	0.0138	CbGeAlD
Adenosine—ADK—nervous system—acquired immunodeficiency syndrome	0.000568	0.0135	CbGeAlD
Adenosine—DPP4—nervous system—acquired immunodeficiency syndrome	0.000551	0.0131	CbGeAlD
Adenosine—ADK—central nervous system—acquired immunodeficiency syndrome	0.000547	0.013	CbGeAlD
Adenosine—ADORA1—nervous system—acquired immunodeficiency syndrome	0.000546	0.013	CbGeAlD
Adenosine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—ALB—acquired immunodeficiency syndrome	0.000542	0.0293	CbGpPWpGaD
Adenosine—ADA—brain—acquired immunodeficiency syndrome	0.000531	0.0127	CbGeAlD
Adenosine—DPP4—central nervous system—acquired immunodeficiency syndrome	0.00053	0.0126	CbGeAlD
Adenosine—ADORA1—central nervous system—acquired immunodeficiency syndrome	0.000526	0.0125	CbGeAlD
Adenosine—ADA—lymph node—acquired immunodeficiency syndrome	0.000514	0.0122	CbGeAlD
Adenosine—ADORA2A—brain—acquired immunodeficiency syndrome	0.000484	0.0115	CbGeAlD
Adenosine—ADORA2A—Circadian rythm related genes—CARTPT—acquired immunodeficiency syndrome	0.000474	0.0256	CbGpPWpGaD
Adenosine—ADK—brain—acquired immunodeficiency syndrome	0.000434	0.0103	CbGeAlD
Adenosine—Glucosamine—TNF—acquired immunodeficiency syndrome	0.000424	0.131	CrCbGaD
Adenosine—DPP4—brain—acquired immunodeficiency syndrome	0.000421	0.01	CbGeAlD
Adenosine—ADK—lymph node—acquired immunodeficiency syndrome	0.00042	0.01	CbGeAlD
Adenosine—ADORA1—brain—acquired immunodeficiency syndrome	0.000417	0.00995	CbGeAlD
Adenosine—ADORA2A—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.00041	0.0222	CbGpPWpGaD
Adenosine—DPP4—lymph node—acquired immunodeficiency syndrome	0.000407	0.00969	CbGeAlD
Adenosine—ADORA1—lymph node—acquired immunodeficiency syndrome	0.000403	0.00961	CbGeAlD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000384	0.0208	CbGpPWpGaD
Adenosine—DPP4—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.000372	0.0201	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000326	0.0177	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000292	0.0158	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.000252	0.0136	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000248	0.0134	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000232	0.0126	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00021	0.0114	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000198	0.0107	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.000192	0.0104	CbGpPWpGaD
Adenosine—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000187	0.00209	CcSEcCtD
Adenosine—Cough—Indinavir—acquired immunodeficiency syndrome	0.000187	0.00209	CcSEcCtD
Adenosine—Agitation—Efavirenz—acquired immunodeficiency syndrome	0.000186	0.00208	CcSEcCtD
Adenosine—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.000185	0.00207	CcSEcCtD
Adenosine—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.00207	CcSEcCtD
Adenosine—Pain—Stavudine—acquired immunodeficiency syndrome	0.000185	0.00207	CcSEcCtD
Adenosine—Shock—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.00207	CcSEcCtD
Adenosine—Angioedema—Efavirenz—acquired immunodeficiency syndrome	0.000185	0.00207	CcSEcCtD
Adenosine—Tinnitus—Saquinavir—acquired immunodeficiency syndrome	0.000184	0.00206	CcSEcCtD
Adenosine—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.00206	CcSEcCtD
Adenosine—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.000183	0.00205	CcSEcCtD
Adenosine—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.00204	CcSEcCtD
Adenosine—Chest pain—Indinavir—acquired immunodeficiency syndrome	0.000182	0.00204	CcSEcCtD
Adenosine—Pain—Abacavir—acquired immunodeficiency syndrome	0.000182	0.00204	CcSEcCtD
Adenosine—Anxiety—Indinavir—acquired immunodeficiency syndrome	0.000181	0.00203	CcSEcCtD
Adenosine—Hyperhidrosis—Zidovudine—acquired immunodeficiency syndrome	0.000181	0.00203	CcSEcCtD
Adenosine—Syncope—Efavirenz—acquired immunodeficiency syndrome	0.000181	0.00203	CcSEcCtD
Adenosine—Tremor—Delavirdine—acquired immunodeficiency syndrome	0.000181	0.00203	CcSEcCtD
Adenosine—Discomfort—Indinavir—acquired immunodeficiency syndrome	0.00018	0.00202	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000179	0.00967	CbGpPWpGaD
Adenosine—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000179	0.002	CcSEcCtD
Adenosine—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000178	0.002	CcSEcCtD
Adenosine—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.002	CcSEcCtD
Adenosine—Dry mouth—Indinavir—acquired immunodeficiency syndrome	0.000178	0.00199	CcSEcCtD
Adenosine—Agitation—Delavirdine—acquired immunodeficiency syndrome	0.000178	0.00199	CcSEcCtD
Adenosine—Urticaria—Nevirapine—acquired immunodeficiency syndrome	0.000178	0.00199	CcSEcCtD
Adenosine—Loss of consciousness—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00199	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000177	0.00958	CbGpPWpGaD
Adenosine—Angioedema—Delavirdine—acquired immunodeficiency syndrome	0.000177	0.00198	CcSEcCtD
Adenosine—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.00198	CcSEcCtD
Adenosine—Tension—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00197	CcSEcCtD
Adenosine—Dysgeusia—Ritonavir—acquired immunodeficiency syndrome	0.000175	0.00196	CcSEcCtD
Adenosine—Convulsion—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.00196	CcSEcCtD
Adenosine—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.000174	0.00196	CcSEcCtD
Adenosine—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.00195	CcSEcCtD
Adenosine—Nervousness—Ritonavir—acquired immunodeficiency syndrome	0.000174	0.00195	CcSEcCtD
Adenosine—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.000173	0.00194	CcSEcCtD
Adenosine—Syncope—Delavirdine—acquired immunodeficiency syndrome	0.000173	0.00194	CcSEcCtD
Adenosine—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.000173	0.00194	CcSEcCtD
Adenosine—ADA—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000172	0.00931	CbGpPWpGaD
Adenosine—Urticaria—Nelfinavir—acquired immunodeficiency syndrome	0.000172	0.00193	CcSEcCtD
Adenosine—Chest pain—Efavirenz—acquired immunodeficiency syndrome	0.000172	0.00193	CcSEcCtD
Adenosine—Rash—Amprenavir—acquired immunodeficiency syndrome	0.000172	0.00193	CcSEcCtD
Adenosine—Dermatitis—Amprenavir—acquired immunodeficiency syndrome	0.000172	0.00193	CcSEcCtD
Adenosine—Shock—Indinavir—acquired immunodeficiency syndrome	0.000172	0.00192	CcSEcCtD
Adenosine—Urticaria—Stavudine—acquired immunodeficiency syndrome	0.000171	0.00192	CcSEcCtD
Adenosine—Anxiety—Efavirenz—acquired immunodeficiency syndrome	0.000171	0.00192	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Zidovudine—acquired immunodeficiency syndrome	0.000171	0.00192	CcSEcCtD
Adenosine—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000171	0.00191	CcSEcCtD
Adenosine—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.00191	CcSEcCtD
Adenosine—Discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.0019	CcSEcCtD
Adenosine—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.0019	CcSEcCtD
Adenosine—Loss of consciousness—Delavirdine—acquired immunodeficiency syndrome	0.00017	0.0019	CcSEcCtD
Adenosine—Urticaria—Abacavir—acquired immunodeficiency syndrome	0.000169	0.00189	CcSEcCtD
Adenosine—Hyperhidrosis—Indinavir—acquired immunodeficiency syndrome	0.000169	0.00189	CcSEcCtD
Adenosine—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.00189	CcSEcCtD
Adenosine—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000168	0.00189	CcSEcCtD
Adenosine—Dysgeusia—Saquinavir—acquired immunodeficiency syndrome	0.000168	0.00189	CcSEcCtD
Adenosine—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000168	0.00189	CcSEcCtD
Adenosine—Dry mouth—Efavirenz—acquired immunodeficiency syndrome	0.000168	0.00188	CcSEcCtD
Adenosine—Tremor—Ritonavir—acquired immunodeficiency syndrome	0.000167	0.00188	CcSEcCtD
Adenosine—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00187	CcSEcCtD
Adenosine—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000167	0.00187	CcSEcCtD
Adenosine—Somnolence—Zidovudine—acquired immunodeficiency syndrome	0.000167	0.00187	CcSEcCtD
Adenosine—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000166	0.00186	CcSEcCtD
Adenosine—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.000165	0.00185	CcSEcCtD
Adenosine—Chest pain—Delavirdine—acquired immunodeficiency syndrome	0.000165	0.00184	CcSEcCtD
Adenosine—Agitation—Ritonavir—acquired immunodeficiency syndrome	0.000164	0.00184	CcSEcCtD
Adenosine—Anxiety—Delavirdine—acquired immunodeficiency syndrome	0.000164	0.00184	CcSEcCtD
Adenosine—Discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.00182	CcSEcCtD
Adenosine—Shock—Efavirenz—acquired immunodeficiency syndrome	0.000162	0.00182	CcSEcCtD
Adenosine—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.000162	0.00182	CcSEcCtD
Adenosine—Tremor—Saquinavir—acquired immunodeficiency syndrome	0.000161	0.00181	CcSEcCtD
Adenosine—Tension—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.0018	CcSEcCtD
Adenosine—Dry mouth—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.0018	CcSEcCtD
Adenosine—Tachycardia—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.0018	CcSEcCtD
Adenosine—Dysgeusia—Lamivudine—acquired immunodeficiency syndrome	0.000161	0.0018	CcSEcCtD
Adenosine—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00016	0.0018	CcSEcCtD
Adenosine—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00016	0.0018	CcSEcCtD
Adenosine—Syncope—Ritonavir—acquired immunodeficiency syndrome	0.00016	0.0018	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00016	0.00866	CbGpPWpGaD
Adenosine—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00016	0.00179	CcSEcCtD
Adenosine—Nervousness—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.00179	CcSEcCtD
Adenosine—Hyperhidrosis—Efavirenz—acquired immunodeficiency syndrome	0.000159	0.00179	CcSEcCtD
Adenosine—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.000159	0.00178	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Indinavir—acquired immunodeficiency syndrome	0.000159	0.00178	CcSEcCtD
Adenosine—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000159	0.00178	CcSEcCtD
Adenosine—ADK—Metabolism—TAT—acquired immunodeficiency syndrome	0.000159	0.00859	CbGpPWpGaD
Adenosine—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000158	0.00177	CcSEcCtD
Adenosine—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000158	0.00177	CcSEcCtD
Adenosine—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.00177	CcSEcCtD
Adenosine—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.00176	CcSEcCtD
Adenosine—Rash—Didanosine—acquired immunodeficiency syndrome	0.000157	0.00176	CcSEcCtD
Adenosine—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000157	0.00176	CcSEcCtD
Adenosine—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000157	0.00176	CcSEcCtD
Adenosine—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000157	0.00176	CcSEcCtD
Adenosine—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.00175	CcSEcCtD
Adenosine—Headache—Didanosine—acquired immunodeficiency syndrome	0.000156	0.00175	CcSEcCtD
Adenosine—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000156	0.00174	CcSEcCtD
Adenosine—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000155	0.00174	CcSEcCtD
Adenosine—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000155	0.00174	CcSEcCtD
Adenosine—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000155	0.00174	CcSEcCtD
Adenosine—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000155	0.00174	CcSEcCtD
Adenosine—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.00174	CcSEcCtD
Adenosine—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.00173	CcSEcCtD
Adenosine—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000154	0.00173	CcSEcCtD
Adenosine—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.00173	CcSEcCtD
Adenosine—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000154	0.00172	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.000153	0.00826	CbGpPWpGaD
Adenosine—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000153	0.00171	CcSEcCtD
Adenosine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000152	0.00171	CcSEcCtD
Adenosine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.0017	CcSEcCtD
Adenosine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000152	0.0017	CcSEcCtD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000152	0.0082	CbGpPWpGaD
Adenosine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.00169	CcSEcCtD
Adenosine—ADORA2B—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	0.000151	0.00814	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00015	0.00814	CbGpPWpGaD
Adenosine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.00168	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00015	0.00168	CcSEcCtD
Adenosine—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.00168	CcSEcCtD
Adenosine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00015	0.00168	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00015	0.00811	CbGpPWpGaD
Adenosine—Pain—Indinavir—acquired immunodeficiency syndrome	0.000149	0.00167	CcSEcCtD
Adenosine—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000149	0.00167	CcSEcCtD
Adenosine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00167	CcSEcCtD
Adenosine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.00167	CcSEcCtD
Adenosine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.00166	CcSEcCtD
Adenosine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000148	0.00166	CcSEcCtD
Adenosine—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000148	0.00165	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.000148	0.00799	CbGpPWpGaD
Adenosine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000147	0.00165	CcSEcCtD
Adenosine—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000147	0.00165	CcSEcCtD
Adenosine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00165	CcSEcCtD
Adenosine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000147	0.00164	CcSEcCtD
Adenosine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.00164	CcSEcCtD
Adenosine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000146	0.00164	CcSEcCtD
Adenosine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.00162	CcSEcCtD
Adenosine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.00162	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.00161	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000144	0.00777	CbGpPWpGaD
Adenosine—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.00161	CcSEcCtD
Adenosine—ADORA2A—Monoamine Transport—TNF—acquired immunodeficiency syndrome	0.000143	0.00775	CbGpPWpGaD
Adenosine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000143	0.0016	CcSEcCtD
Adenosine—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.0016	CcSEcCtD
Adenosine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.0016	CcSEcCtD
Adenosine—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000143	0.0016	CcSEcCtD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000143	0.00771	CbGpPWpGaD
Adenosine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.0016	CcSEcCtD
Adenosine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.00159	CcSEcCtD
Adenosine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000142	0.00159	CcSEcCtD
Adenosine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.00159	CcSEcCtD
Adenosine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.00158	CcSEcCtD
Adenosine—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000141	0.00158	CcSEcCtD
Adenosine—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.00158	CcSEcCtD
Adenosine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000141	0.00158	CcSEcCtD
Adenosine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000141	0.00158	CcSEcCtD
Adenosine—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000141	0.00158	CcSEcCtD
Adenosine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.00157	CcSEcCtD
Adenosine—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00014	0.00157	CcSEcCtD
Adenosine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.00157	CcSEcCtD
Adenosine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000139	0.00156	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000139	0.00751	CbGpPWpGaD
Adenosine—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000139	0.00155	CcSEcCtD
Adenosine—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.00155	CcSEcCtD
Adenosine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.00155	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000138	0.00747	CbGpPWpGaD
Adenosine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.00154	CcSEcCtD
Adenosine—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000137	0.00154	CcSEcCtD
Adenosine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.00153	CcSEcCtD
Adenosine—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000137	0.00153	CcSEcCtD
Adenosine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.00153	CcSEcCtD
Adenosine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.00153	CcSEcCtD
Adenosine—Rash—Stavudine—acquired immunodeficiency syndrome	0.000136	0.00153	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000136	0.00736	CbGpPWpGaD
Adenosine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000136	0.00152	CcSEcCtD
Adenosine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.00152	CcSEcCtD
Adenosine—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000136	0.00152	CcSEcCtD
Adenosine—Headache—Stavudine—acquired immunodeficiency syndrome	0.000135	0.00152	CcSEcCtD
Adenosine—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000135	0.00152	CcSEcCtD
Adenosine—ADK—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000135	0.0073	CbGpPWpGaD
Adenosine—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.00151	CcSEcCtD
Adenosine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000135	0.00151	CcSEcCtD
Adenosine—Rash—Abacavir—acquired immunodeficiency syndrome	0.000134	0.0015	CcSEcCtD
Adenosine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000134	0.0015	CcSEcCtD
Adenosine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.0015	CcSEcCtD
Adenosine—Headache—Abacavir—acquired immunodeficiency syndrome	0.000133	0.00149	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00149	CcSEcCtD
Adenosine—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.00149	CcSEcCtD
Adenosine—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.00148	CcSEcCtD
Adenosine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.00147	CcSEcCtD
Adenosine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000131	0.00147	CcSEcCtD
Adenosine—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000131	0.00147	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000131	0.00706	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000131	0.00706	CbGpPWpGaD
Adenosine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00146	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00013	0.00703	CbGpPWpGaD
Adenosine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.00145	CcSEcCtD
Adenosine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00145	CcSEcCtD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	0.000129	0.00697	CbGpPWpGaD
Adenosine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000129	0.00144	CcSEcCtD
Adenosine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000129	0.00144	CcSEcCtD
Adenosine—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000128	0.00144	CcSEcCtD
Adenosine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.00143	CcSEcCtD
Adenosine—ADORA1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000127	0.0069	CbGpPWpGaD
Adenosine—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000126	0.00142	CcSEcCtD
Adenosine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000126	0.00141	CcSEcCtD
Adenosine—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.0014	CcSEcCtD
Adenosine—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000125	0.0014	CcSEcCtD
Adenosine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.0014	CcSEcCtD
Adenosine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.0014	CcSEcCtD
Adenosine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.0014	CcSEcCtD
Adenosine—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.0014	CcSEcCtD
Adenosine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.00139	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000122	0.00661	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000122	0.00661	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000122	0.00661	CbGpPWpGaD
Adenosine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.00137	CcSEcCtD
Adenosine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000121	0.00136	CcSEcCtD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	0.000121	0.00656	CbGpPWpGaD
Adenosine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.00012	0.00135	CcSEcCtD
Adenosine—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00012	0.00135	CcSEcCtD
Adenosine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00134	CcSEcCtD
Adenosine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000119	0.00134	CcSEcCtD
Adenosine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.00133	CcSEcCtD
Adenosine—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.00133	CcSEcCtD
Adenosine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000118	0.00133	CcSEcCtD
Adenosine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.00132	CcSEcCtD
Adenosine—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000118	0.00132	CcSEcCtD
Adenosine—SLC28A3—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000116	0.00629	CbGpPWpGaD
Adenosine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.0013	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000116	0.00629	CbGpPWpGaD
Adenosine—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.0013	CcSEcCtD
Adenosine—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000115	0.00129	CcSEcCtD
Adenosine—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.00128	CcSEcCtD
Adenosine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000113	0.00127	CcSEcCtD
Adenosine—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.00125	CcSEcCtD
Adenosine—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.00125	CcSEcCtD
Adenosine—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000111	0.00124	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00011	0.00597	CbGpPWpGaD
Adenosine—Rash—Indinavir—acquired immunodeficiency syndrome	0.00011	0.00123	CcSEcCtD
Adenosine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.00011	0.00123	CcSEcCtD
Adenosine—ADORA2B—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000109	0.00592	CbGpPWpGaD
Adenosine—Headache—Indinavir—acquired immunodeficiency syndrome	0.000109	0.00122	CcSEcCtD
Adenosine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.00122	CcSEcCtD
Adenosine—ADA—Metabolism—TAT—acquired immunodeficiency syndrome	0.000108	0.00584	CbGpPWpGaD
Adenosine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000107	0.0012	CcSEcCtD
Adenosine—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.00119	CcSEcCtD
Adenosine—ADORA2A—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000105	0.00569	CbGpPWpGaD
Adenosine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00117	CcSEcCtD
Adenosine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000105	0.00117	CcSEcCtD
Adenosine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.00117	CcSEcCtD
Adenosine—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.00116	CcSEcCtD
Adenosine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000104	0.00116	CcSEcCtD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000104	0.00562	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000104	0.00562	CbGpPWpGaD
Adenosine—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000104	0.00116	CcSEcCtD
Adenosine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000103	0.00116	CcSEcCtD
Adenosine—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000103	0.00116	CcSEcCtD
Adenosine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000101	0.00113	CcSEcCtD
Adenosine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.0001	0.00112	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	9.95e-05	0.00538	CbGpPWpGaD
Adenosine—Rash—Delavirdine—acquired immunodeficiency syndrome	9.95e-05	0.00111	CcSEcCtD
Adenosine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.94e-05	0.00111	CcSEcCtD
Adenosine—ADORA1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	9.93e-05	0.00537	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	9.89e-05	0.00535	CbGpPWpGaD
Adenosine—Headache—Delavirdine—acquired immunodeficiency syndrome	9.88e-05	0.00111	CcSEcCtD
Adenosine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.87e-05	0.00111	CcSEcCtD
Adenosine—ADORA2A—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	9.84e-05	0.00533	CbGpPWpGaD
Adenosine—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.79e-05	0.0011	CcSEcCtD
Adenosine—ADORA2B—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	9.77e-05	0.00528	CbGpPWpGaD
Adenosine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9.65e-05	0.00108	CcSEcCtD
Adenosine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	9.61e-05	0.00108	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	9.43e-05	0.0051	CbGpPWpGaD
Adenosine—Nausea—Delavirdine—acquired immunodeficiency syndrome	9.37e-05	0.00105	CcSEcCtD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	9.36e-05	0.00506	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	9.3e-05	0.00503	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	9.3e-05	0.00503	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	9.3e-05	0.00503	CbGpPWpGaD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	9.29e-05	0.00503	CbGpPWpGaD
Adenosine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	9.28e-05	0.00104	CcSEcCtD
Adenosine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	9.27e-05	0.00104	CcSEcCtD
Adenosine—Rash—Ritonavir—acquired immunodeficiency syndrome	9.2e-05	0.00103	CcSEcCtD
Adenosine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	9.19e-05	0.00103	CcSEcCtD
Adenosine—ADA—Metabolism—AGPS—acquired immunodeficiency syndrome	9.17e-05	0.00496	CbGpPWpGaD
Adenosine—Headache—Ritonavir—acquired immunodeficiency syndrome	9.14e-05	0.00102	CcSEcCtD
Adenosine—ADORA2B—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	9.08e-05	0.00491	CbGpPWpGaD
Adenosine—ADORA1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	8.95e-05	0.00484	CbGpPWpGaD
Adenosine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.93e-05	0.001	CcSEcCtD
Adenosine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.86e-05	0.000992	CcSEcCtD
Adenosine—ADORA2B—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	8.86e-05	0.00479	CbGpPWpGaD
Adenosine—Rash—Saquinavir—acquired immunodeficiency syndrome	8.85e-05	0.000992	CcSEcCtD
Adenosine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.84e-05	0.000991	CcSEcCtD
Adenosine—Headache—Saquinavir—acquired immunodeficiency syndrome	8.8e-05	0.000986	CcSEcCtD
Adenosine—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.66e-05	0.000971	CcSEcCtD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	8.52e-05	0.00461	CbGpPWpGaD
Adenosine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	8.52e-05	0.000954	CcSEcCtD
Adenosine—Rash—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000946	CcSEcCtD
Adenosine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	8.44e-05	0.000945	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	8.41e-05	0.00455	CbGpPWpGaD
Adenosine—Headache—Lamivudine—acquired immunodeficiency syndrome	8.39e-05	0.00094	CcSEcCtD
Adenosine—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	8.37e-05	0.00453	CbGpPWpGaD
Adenosine—Nausea—Saquinavir—acquired immunodeficiency syndrome	8.34e-05	0.000934	CcSEcCtD
Adenosine—ADORA1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	8.3e-05	0.00449	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	8.21e-05	0.00444	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	8.02e-05	0.00434	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	8.02e-05	0.00434	CbGpPWpGaD
Adenosine—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.96e-05	0.000891	CcSEcCtD
Adenosine—ADORA1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	7.91e-05	0.00428	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	7.91e-05	0.00428	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	7.9e-05	0.00427	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	7.72e-05	0.00418	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	7.53e-05	0.00407	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	7.18e-05	0.00388	CbGpPWpGaD
Adenosine—ADORA1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	7.11e-05	0.00385	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	7.07e-05	0.00383	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	6.98e-05	0.00378	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	6.49e-05	0.00351	CbGpPWpGaD
Adenosine—ADORA2A—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	6.41e-05	0.00347	CbGpPWpGaD
Adenosine—ADORA2B—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	6.37e-05	0.00345	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	6.1e-05	0.0033	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	6.1e-05	0.0033	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	6.1e-05	0.0033	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	6.01e-05	0.00325	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	5.96e-05	0.00323	CbGpPWpGaD
Adenosine—SLC28A3—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	5.91e-05	0.0032	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	5.81e-05	0.00315	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	5.61e-05	0.00304	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	5.59e-05	0.00302	CbGpPWpGaD
Adenosine—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	5.49e-05	0.00297	CbGpPWpGaD
Adenosine—ADORA1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	5.42e-05	0.00293	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	5.39e-05	0.00292	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	5.37e-05	0.0029	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	5.37e-05	0.0029	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	5.25e-05	0.00284	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	5.25e-05	0.00284	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	5.07e-05	0.00275	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.85e-05	0.00263	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.77e-05	0.00258	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.77e-05	0.00258	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	4.77e-05	0.00258	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	4.75e-05	0.00257	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	4.64e-05	0.00251	CbGpPWpGaD
Adenosine—ADA—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	4.63e-05	0.00251	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	4.56e-05	0.00247	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	4.56e-05	0.00247	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	4.47e-05	0.00242	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	4.47e-05	0.00242	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	4.31e-05	0.00233	CbGpPWpGaD
Adenosine—ADORA2A—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	4.18e-05	0.00226	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	4.13e-05	0.00223	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	4.06e-05	0.0022	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	4.06e-05	0.0022	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	4e-05	0.00216	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.94e-05	0.00213	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	3.68e-05	0.00199	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	3.67e-05	0.00199	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.63e-05	0.00196	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.6e-05	0.00195	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.58e-05	0.00193	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	3.52e-05	0.00191	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	3.52e-05	0.00191	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	3.45e-05	0.00187	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	3.45e-05	0.00187	CbGpPWpGaD
Adenosine—ADORA1—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	3.44e-05	0.00186	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	3.4e-05	0.00184	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	3.35e-05	0.00181	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	3.33e-05	0.0018	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	3.31e-05	0.00179	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	3.27e-05	0.00177	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	3.19e-05	0.00172	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	3.13e-05	0.00169	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	3.13e-05	0.00169	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	3.09e-05	0.00167	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	3.06e-05	0.00166	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	3.04e-05	0.00165	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	3e-05	0.00162	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.82e-05	0.00153	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.82e-05	0.00153	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.82e-05	0.00153	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.78e-05	0.0015	CbGpPWpGaD
Adenosine—ADK—Metabolism—ALB—acquired immunodeficiency syndrome	2.77e-05	0.0015	CbGpPWpGaD
Adenosine—ADORA2A—Circadian rythm related genes—IL6—acquired immunodeficiency syndrome	2.66e-05	0.00144	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	2.62e-05	0.00142	CbGpPWpGaD
Adenosine—ADORA2A—NGF signalling via TRKA from the plasma membrane—IL6—acquired immunodeficiency syndrome	2.61e-05	0.00141	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	2.58e-05	0.0014	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	2.55e-05	0.00138	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	2.4e-05	0.0013	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	2.4e-05	0.0013	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	2.38e-05	0.00129	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	2.36e-05	0.00128	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	2.35e-05	0.00127	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	2.18e-05	0.00118	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	2.15e-05	0.00116	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	2.14e-05	0.00116	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	2.11e-05	0.00114	CbGpPWpGaD
Adenosine—ADORA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	2.08e-05	0.00113	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by NGF—IL6—acquired immunodeficiency syndrome	2.01e-05	0.00109	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.97e-05	0.00106	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.93e-05	0.00105	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.89e-05	0.00102	CbGpPWpGaD
Adenosine—ADA—Metabolism—ALB—acquired immunodeficiency syndrome	1.88e-05	0.00102	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.85e-05	0.001	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.85e-05	0.001	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.82e-05	0.000987	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.8e-05	0.000972	CbGpPWpGaD
Adenosine—ADORA1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.77e-05	0.000957	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.64e-05	0.000889	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.61e-05	0.000869	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.41e-05	0.000762	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.39e-05	0.00075	CbGpPWpGaD
Adenosine—ADORA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.37e-05	0.000739	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.27e-05	0.000686	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000671	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000604	CbGpPWpGaD
Adenosine—ADORA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.11e-05	0.000601	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.49e-06	0.000514	CbGpPWpGaD
Adenosine—ADORA1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.44e-06	0.000511	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.33e-06	0.000396	CbGpPWpGaD
Adenosine—ADORA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.29e-06	0.000395	CbGpPWpGaD
Adenosine—ADORA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.56e-06	0.000355	CbGpPWpGaD
Adenosine—ADORA1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.58e-06	0.000302	CbGpPWpGaD
Adenosine—ADORA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.31e-06	0.000233	CbGpPWpGaD
